Skip to content
  • Thursday, 19 November 2026
  • 12:50 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • A targeted paper shredder for the genome: new CRISPR tech tears up diseased cells’ DNA
Biotech & Genetic Research

A targeted paper shredder for the genome: new CRISPR tech tears up diseased cells’ DNA

Jia Lissa Jun 24, 2026 0

This innovative CRISPR platform leverages a recently identified nuclease called Cas12a2, a protein capable of orchestrating RNA-triggered DNA shredding to…

Read More
Study: Toxic Exposure in Pregnancy May Drive Disease Risk Across GenerationsIndiana University Scientists Pioneer High-Resolution Multiplex Imaging Technique to Map Bone Marrow Microenvironments in Mouse ModelsAmazon Web Services Launches AI Drug Discovery Platform to Accelerate Novel Therapy DevelopmentTWiV 1289: Building a better hepatitis B trap
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Vertex Pharmaceuticals Extends Precision Medicine Alliance with Genomics in Four-Year Deal Valued at Over $220mBridging gaps in rare disease drug access requires strategic rethink  – Pharmaceutical TechnologyPrecision CRISPR-Activation in Brain Organoids Uncovers Promising Early Targets to Intercept Autism Spectrum Disorder DevelopmentSomething strange is living beneath the skin of deep-sea pigs
YOU MAY HAVE MISSED
Pharmaceutical R&D
Vertex Pharmaceuticals Extends Precision Medicine Alliance with Genomics in Four-Year Deal Valued at Over $220m
Teuku Ryan Nov 19, 2026
Pharmaceutical R&D
Bridging gaps in rare disease drug access requires strategic rethink  – Pharmaceutical Technology
Teuku Ryan Nov 19, 2026
Biotech & Genetic Research
Precision CRISPR-Activation in Brain Organoids Uncovers Promising Early Targets to Intercept Autism Spectrum Disorder Development
Jia Lissa Nov 19, 2026
Molecular & Cell Biology
Something strange is living beneath the skin of deep-sea pigs
Angie Faith Nov 19, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ